285 related articles for article (PubMed ID: 22284251)
1. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
[TBL] [Abstract][Full Text] [Related]
2. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
3. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
Han SW; Won YW; Yi JH; Kim HJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
[TBL] [Abstract][Full Text] [Related]
4. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
7. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.
Hernández D; Muriel A; Abraira V; Pérez G; Porrini E; Marrero D; Zamora J; González-Posada JM; Delgado P; Rufino M; Torres A
Nephrol Dial Transplant; 2012 Jan; 27(1):417-22. PubMed ID: 21622985
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).
Fujita M; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
Am J Cardiol; 2007 Dec; 100(12):1750-3. PubMed ID: 18082520
[TBL] [Abstract][Full Text] [Related]
10. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
Thilly N; Bayat S; Alla F; Kessler M; Briançon S; Frimat L
Clin Transplant; 2008; 22(4):439-46. PubMed ID: 18318741
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
[TBL] [Abstract][Full Text] [Related]
13. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
[TBL] [Abstract][Full Text] [Related]
15. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
16. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
Lai HM; Aronow WS; Kruger A; Desai H; Amin H; Frishman WH; Cohen M; Sorbera C
Am J Cardiol; 2008 Jul; 102(1):77-8. PubMed ID: 18572039
[TBL] [Abstract][Full Text] [Related]
18. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
Chae YK; Valsecchi ME; Kim J; Bianchi AL; Khemasuwan D; Desai A; Tester W
Cancer Invest; 2011 Nov; 29(9):585-93. PubMed ID: 21936625
[TBL] [Abstract][Full Text] [Related]
19. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
20. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
Patel D; Mohanty P; Di Biase L; Wang Y; Shaheen MH; Sanchez JE; Horton RP; Gallinghouse GJ; Zagrodzky JD; Bailey SM; Burkhardt JD; Lewis WR; Diaz A; Beheiry S; Hongo R; Al-Ahmad A; Wang P; Schweikert R; Natale A
Europace; 2010 Mar; 12(3):322-30. PubMed ID: 20064822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
